biotech
GlaxoSmithKline Blocks Sale Of Generic Flonase
Filed in archive Drugs, Vaccines and Therapeutics , Patents and Intellectual Property Rights by ruth on February 28, 2006
flonase.jpg

A federal judge in Baltimore issued a 10-day restraining order, blocking the shipment and sales of Fluticasone Propionate Nasal Spray (from Roxane Laboratories Inc.'s , FDA-approved last week) and Par Pharmaceutical Companies Inc.'s generic version of Flonase (GlaxoSmithKline), a nasal spray that treats allergic and nonallergic nasal symptoms.

GlaxoSmithKline obtained the restraining order one day after the company sued the FDA for allegedly ailed to follow its own regulations in approving the Flonase generic and failed to apply the same quality standards.

See full story from LA Times.

Permalink: GlaxoSmithKline Blocks Sale Of Generic Flonase
Tags: allergies  nasal  biotech  generic  flonase  generic+flonase  glaxosmithkline+blocks  sale+generic 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/16406
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for GlaxoSmithKline Blocks Sale Of Generic Flonase:

  • Currently 8.25/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.25 out of 4 vote(s) cast.
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!